NCT04891406View on ClinicalTrials.gov

A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

January 20, 2021

Conditions
Healthy Volunteers
Interventions
OTHER

A

Use of product A (ZoneX #2, white tobacco-free nicotine pouch, 5.8 mg nicotine/pouch) for 20 minutes

OTHER

B

Use of product B (ZoneX #3, white tobacco-free nicotine pouch, 10.1 mg nicotine/pouch) for 20 minutes

OTHER

C

Use of product C (Skruf snus fresh slim white, 10.9 mg nicotine/pouch) for 20 minutes

OTHER

D

Use of product D (Nicotine pouch, 10.6 mg/pouch) for 20 minutes

OTHER

E

Use of product E (Marlboro Gold, conventional cigarette, 0.8 mg nicotine/cigarette) for approximately 5 minutes

Trial Locations (1)

SE-752 37

CTC Clinical Trial Consultants AB (CTC), Uppsala

All Listed Sponsors
lead

Imperial Brands PLC

INDUSTRY

NCT04891406 - A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products | Biotech Hunter | Biotech Hunter